NEW YORK, Aug. 28 – Physiome Sciences has licensed its PathwayPrism modeling technology to 3rd Millennium to help it develop products for Huntington’s disease, the companies said on Tuesday.

The deal will allow Cambridge, Mass.-based 3rd Millennium and its academic partners “to visualize and stimulate pathways” involved in the disease, the companies said in a statement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.